| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697596 | Cancer Treatment Reviews | 2017 | 22 Pages |
Abstract
Compared to control groups, immunotherapeutics and drugs targeting oncogenes or angiogenesis improve efficacy to a greater degree than chemotherapy. Immunotherapy appears to have better safety and tolerability profile compared to other cancer therapies. Market price of drugs is not related to efficacy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Tristan A. Barnes, Eitan Amir, Arnoud J. Templeton, Susana Gomez-Garcia, Beatriz Navarro, Bostjan Seruga, Alberto Ocana,